$HUBC Cashflow Statement | Understand Stock

$HUBC

$0.13 -$0.01 (9.38%) Close

$HUBC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Cash flows from operating activities:
Loss
Adjustments to the profit or loss items:
Finance expenses, net
Other expenses
Financial liabilities recorded as listing expenses
Finance expenses related to convertible loans and warrants
Issuance of shares to consultants
Revaluation of liability to Legacy
ELOC
Share listing expenses
Cost of share-based payment to consultants and employees
Cost of share-based payment
Issuance of prefunded warrants
Depreciation and amortization
Impairment of goodwill and intangible assets
Change in employee benefit liabilities, net
Gain on loss of control in subsidiaries
Change in deferred tax liabilities
Adjustments to the profit or loss items
Changes in asset and liability items:
Decrease (increase) in trade receivables
Decrease (increase) in other assets
Increase (decrease) in trade payables
Decrease (increase) in inventories
Change in balances of government grants
Decrease (increase) in other accounts payable
Changes in asset and liability
Cash paid and received during the year for:
Interest paid, net
Taxes paid
Cash paid and received during the year
Net cash used in operating activities
Cash flows from investing activities:
Investment in restricted bank deposit
(Investment in) restricted bank deposit
Withdrawal from restricted cash
Change in long-term deposits
Purchase of property and equipment
Assets acquisition
Credit line to a related party
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Short-term loans, net
Repayment of lease liabilities
Receipt on account of issuance of shares
Dividend distribution to non-controlling interests
Government grants
Exercise of options and convertible warrants
Repayment of short-term loans
Acquisition of non-controlling interest
Net cash provided by financing activities

Exchange rate differences on cash and cash equivalents
(Decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Non-cash transactions:
BST merger
Right-of-use asset and liability
Assets acquisition
actuarial (gain) loss from defined benefit plan
Employee benefit assets and liabilities
Reclassification of deferred issuance cost to equity
Dividend distribution to non-controlling interests
Reclassification of liability to equity
Exercise of warrants
Conversion of convertible loans

Trade receivables
Right-of-use assets
Goodwill
Intangible assets
Deferred tax asset
Trade payables
Other payables
Liabilities for government grants
Non-controlling interests
Equity

Comments